Literature DB >> 30255413

[Elbow prostheses in rheumatic diseases].

V Rausch1, M Hackl2, T Leschinger2, L P Müller2, K Wegmann2.   

Abstract

When the elbow is destroyed due to rheumatic diseases, the joint can be replaced by a prosthesis and total arthroplasty. Improved pharmaceutical treatment for rheumatic diseases has, however, reduced the number of implantations in these patients. Reported 10-year survival rates of the implant currently achieve 81-90%.; however, due to limited long-term survival of the implant and high complication rates, total elbow arthroplasty should still be used with caution. Continuous technical improvements in the available prostheses and in surgical techniques could lead in the future to a decline in complications, such as aseptic loosening and infections.

Entities:  

Keywords:  Complication rate; Endoprosthesis; Rheumatism; Rheumatoid arthritis; Survival

Mesh:

Year:  2018        PMID: 30255413     DOI: 10.1007/s00393-018-0539-x

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  38 in total

1.  Modeling and finite element analysis of a new revision implant for the elbow.

Authors:  Daniel B Herren; Heidi Ploeg; Daniel Hertig; Rolf Klabunde
Journal:  Clin Orthop Relat Res       Date:  2004-03       Impact factor: 4.176

2.  Coonrad-Morrey total elbow arthroplasty for patients with rheumatoid arthritis: 54 prostheses reviewed at 7 years' average follow-up (maximum, 16 years).

Authors:  Thuy Trang Pham; Stéphanie Delclaux; Sandrine Huguet; Matthieu Wargny; Nicolas Bonnevialle; Pierre Mansat
Journal:  J Shoulder Elbow Surg       Date:  2018-01-04       Impact factor: 3.019

3.  Interposition arthroplasty of the elbow with rheumatoid arthritis.

Authors:  P Ljung; K Jonsson; K Larsson; U Rydholm
Journal:  J Shoulder Elbow Surg       Date:  1996 Mar-Apr       Impact factor: 3.019

Review 4.  Total Elbow Arthroplasty: A Systematic Review.

Authors:  Chantal L Welsink; Kaj T A Lambers; Derek F P van Deurzen; Denise Eygendaal; Michel P J van den Bekerom
Journal:  JBJS Rev       Date:  2017-07

5.  Total elbow arthroplasty: outcomes after triceps-detaching and triceps-sparing approaches.

Authors:  Robert P Dachs; Mark A Fleming; David A Chivers; Henri R Carrara; Jean-Pierre Du Plessis; Basil C Vrettos; Stephen J Roche
Journal:  J Shoulder Elbow Surg       Date:  2015-01-13       Impact factor: 3.019

6.  Indications and reoperation rates for total elbow arthroplasty: an analysis of trends in New York State.

Authors:  David M Gay; Stephen Lyman; Huong Do; Robert N Hotchkiss; Robert G Marx; Aaron Daluiski
Journal:  J Bone Joint Surg Am       Date:  2012-01-18       Impact factor: 5.284

7.  A multicenter, prospective, randomized, controlled trial of open reduction--internal fixation versus total elbow arthroplasty for displaced intra-articular distal humeral fractures in elderly patients.

Authors:  Michael D McKee; Christian J H Veillette; Jeremy A Hall; Emil H Schemitsch; Lisa M Wild; Robert McCormack; Bertrand Perey; Thomas Goetz; Mauri Zomar; Karyn Moon; Scott Mandel; Shirlet Petit; Pierre Guy; Irene Leung
Journal:  J Shoulder Elbow Surg       Date:  2008-09-26       Impact factor: 3.019

8.  Interposition arthroplasty with an Achilles tendon allograft as a salvage procedure for the elbow.

Authors:  A Noelle Larson; Bernard F Morrey
Journal:  J Bone Joint Surg Am       Date:  2008-12       Impact factor: 5.284

9.  Survivorship of the KUDO total elbow prosthesis--comparative study of cemented and uncemented ulnar components: 89 cases followed for an average of 6 years.

Authors:  Huub J L van der Heide; Maarten J de Vos; J-Martijn Brinkman; Denise Eygendaal; Frank H J van den Hoogen; Maarten C de Waal Malefijt
Journal:  Acta Orthop       Date:  2007-04       Impact factor: 3.717

10.  Trends in total elbow arthroplasty in the Medicare population: a nationwide study of records from 2005 to 2012.

Authors:  Jacob J Triplet; Jennifer Kurowicki; Enesi Momoh; Tsun Yee Law; Timothy Niedzielak; Jonathan C Levy
Journal:  J Shoulder Elbow Surg       Date:  2016-07-12       Impact factor: 3.019

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.